Remote detection of Alzheimer's disease pathology using a digital sleep and circadian biomarker: an InSleep46 study

Abstract

Background: Sleep and circadian disruption are associated with increased dementia risk. Digital sleep biomarkers may provide an ecologically valid and low‐burden means of remote population‐level screening for incipient dementia.